Dr.  Adam P. Dicker (Professor of Radiation Oncology) is the Director of the Division of Experimental Radiation Oncology in the Department of Radiation Oncology at Thomas Jefferson University.  He leads the Molecular Targets and Developmental Therapeutics Program at the Kimmel Cancer Center and is responsible for phase I trials with novels agents.

Dr. Dicker graduated from Columbia College and received his M.D. and Ph.D. from Cornell University Medical College.  He then completed an internship in Surgery at Lenox Hill Hospital and completed his residency in Department of Radiation Oncology at the Memorial Sloan-Kettering Cancer Center.

His laboratory research funded by the National Cancer Institute involves studying the role of the Epidermal Growth Factor Receptor (EGFR) and tumor microenvironment in solid tumors.  His research evaluates radiosensitization by EGFR blockade through an understanding of survival signals derived from extracellular matrix.  He currently is studying deregulated NF-kB signaling and its role in cancer biology.  Dr. Dicker’s other research effort builds on the use of zebrafish as a model organism to study molecular mechanisms of damage by radiation and chemotherapy.  Dr. Dicker’s laboratory program uses this model organism in conjunctional with nanotechnology drugs (nanoparticles) to identify novel radiation protectors/mitigators.

Dr. Dicker serves as the Vice Chair for Translational Research and Chair of the Translational Research Committee in the Radiation Therapy Oncology Group (RTOG), a National Cancer Institute sponsored cooperative group.  In addition, he is the principal investigator on a number of “first in man” clinical developmental therapeutic protocols involving novel signal transduction agents at Thomas Jefferson University.  Dr. Dicker is Chair of the ASTRO Radiation Biology and Cancer Committee and also serves as a member of the Corporate Relations Committee.

Dr. Dicker is a board certified radiation oncologist.  Among other honors, he has received an American Cancer Society Fellowship and an ASTRO/ESTRO Travel Grant.